Strategic Design of Amyloid-β Species Fluorescent Probes for Alzheimer’s Disease
Authors:
- 8 February 2022
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 13 (5) , 540-551
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21807075, 21907071)
This publication has 90 references indexed in Scilit:
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Spectral Unmixing Imaging of Wavelength-Responsive Fluorescent Probes: An Application for the Real-Time Report of Amyloid Beta Species in Alzheimer’s DiseaseMolecular Imaging and Biology, 2011
- Non-Conjugated Small Molecule FRET for Differentiating Monomers from Higher Molecular Weight Amyloid Beta SpeciesPLOS ONE, 2011
- Spectroscopic characterization of diverse amyloid fibrils in vitro by the fluorescent dyeNile redMolecular BioSystems, 2011
- Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-β DepositsJournal of the American Chemical Society, 2009
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- Structure of the cross-β spine of amyloid-like fibrilsNature, 2005
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004